Drug recall · August 29, 2012
Mercaptopurine Tablets recall
Why: Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC 49884-922-04), Rx only, Distributed by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977.
- Lots / codes
Lot #s: a) 11A003, 11A004, 11A005, Exp 01/13; 11L071, 11L072, Exp 10/13; b) 11B009, Exp 01/13; 11L073, Exp 10/13
- Quantity
- a) 25,516 bottles; b) 2,569 bottles
- Company
- Prometheus Laboratories Inc., San Diego, CA
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- June 29, 2012 · Voluntary: Firm initiated
- Classified
- August 22, 2012
- Reported
- August 29, 2012
- Ended
- March 27, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mercaptopurine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.